Octreotide Acetate
Pricing Report NDC 25021-454-05

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Octreotide Acetate (NDC 25021-454-05) is $5.96960 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since May 21, 2025.

As a provided by Sagent Pharmaceuticals, this medication is distributed in a 1 VIAL in 1 CARTON / 5 mL in 1 VIAL configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$5.96960
Per ML

Effective Date
May 21, 2025
Data Status
As of Aug 20, 2025
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 VIAL in 1 CARTON / 5 mL in 1 VIAL
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since May 2014, the NADAC wholesale price for (NDC ) has moved within a range of $5.96960 to $14.06880 per ML. Over this 11 years period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$5.9696 - $14.0688
Market Volatility
135.67% Variance
Latest Trend
No Change
Date Unit Price Unit Source Method Rate
May 21, 2025 $5.96960 MLC/I - Chain or Independent PharmacyCode 1, 5G - Generic
May 21, 2025 $5.96960 MLC/I - Chain or Independent PharmacyCode 4, 5G - Generic
Apr 23, 2025 $5.96960 MLC/I - Chain or Independent PharmacyCode 1, 5G - Generic
Mar 19, 2025 $6.02617 MLC/I - Chain or Independent PharmacyCode 1, 5G - Generic
Feb 19, 2025 $6.21711 MLC/I - Chain or Independent PharmacyCode 1, 5G - Generic
Jan 22, 2025 $6.34086 MLC/I - Chain or Independent PharmacyCode 1, 5G - Generic
Dec 18, 2024 $6.54240 MLC/I - Chain or Independent PharmacyCode 1, 5G - Generic
Jan 22, 2020 $9.19720 MLC/I - Chain or Independent PharmacyCode 1, 5G - Generic
Jan 22, 2020 $9.19720 MLC/I - Chain or Independent PharmacyCode 4, 5G - Generic
Apr 12, 2017 $14.06880 MLC/I - Chain or Independent PharmacyCode 4, 5G - Generic
Oct 19, 2016 $14.06880 MLC/I - Chain or Independent PharmacyCode 1, 5G - Generic
Oct 19, 2016 $14.06880 MLC/I - Chain or Independent PharmacyCode 4, 5G - Generic
May 14, 2014 $9.28457 MLC/I - Chain or Independent PharmacyCode 4, 5G - Generic
May 14, 2014 $9.28457 MLC/I - Chain or Independent PharmacyCode 4, 5, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026